ClouDr Group Past Earnings Performance

Past criteria checks 0/6

ClouDr Group has been growing earnings at an average annual rate of 35.2%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 31.1% per year.

Key information

35.2%

Earnings growth rate

54.5%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate31.1%
Return on equity-16.6%
Net Margin-7.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ClouDr Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:H3L Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,013-2831,07589
31 Mar 243,852-3031,12789
31 Dec 233,691-3231,17988
30 Sep 233,551-4691,26282
30 Jun 233,411-6141,34576
31 Mar 233,199-1,1521,32795
31 Dec 222,988-1,6891,308115
30 Sep 222,738-1,8871,277168
30 Jun 222,430-2,8441,186207
31 Mar 222,093-3,4921,123222
31 Dec 211,757-4,1391,060236
30 Sep 211,513-4,7011,134227
31 Dec 20839-2,867943132
31 Dec 19524-55722424
31 Dec 18250-14010519

Quality Earnings: H3L is currently unprofitable.

Growing Profit Margin: H3L is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: H3L is unprofitable, but has reduced losses over the past 5 years at a rate of 35.2% per year.

Accelerating Growth: Unable to compare H3L's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: H3L is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).


Return on Equity

High ROE: H3L has a negative Return on Equity (-16.62%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies